Raymond James Reiterates Outperform Rating on Aquestive Therapeutics (AQST)

Go back to Raymond James Reiterates Outperform Rating on Aquestive Therapeutics (AQST)
(NASDAQ: AQST) Delayed: 4.12 +0.18 (4.57%)
Previous Close $3.94    52 Week High
Open $3.89    52 Week Low
Day High $4.16    P/E N/A 
Day Low $3.81    EPS
Volume 2,356,257